ArticleCase reports in dermatology

Use of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis in Challenging Clinical Scenarios Including Atypical Presentations, Comorbidities, and Tattooed Skin Involvement: Four Case Reports.

Mariateresa Rossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.